GlassScriptPhysician profile
Alexandra Walters
NPI 1215382510
$1,070.18
in general payments reported to CMS, 2019-2025
18 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $254 · 2021: $28.16 · 2022: $462 · 2024: $85.95 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $216.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Preventric Diagnostics, INC. | $370.22 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $194.98 | 2020-2025 | Lifevest |
| Pfizer INC. | $83.80 | 2021-2025 | |
| Abiomed | $60.99 | 2020 | |
| Amgen INC. | $57.07 | 2019 | |
| Novartis Pharmaceuticals Corporation | $46.80 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.48 | 2020-2022 | |
| Boston Scientific Corporation | $29.52 | 2024 | Lux-Dx Insertable Cardiac Monitor |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $23.48 | 2022 | |
| Astellas Pharma US INC | $21.19 | 2019 | |
| Terumo Medical Corporation | $21.12 | 2022 | |
| Lantheus Medical Imaging, INC. | $19.36 | 2020 | |
| Janssen Pharmaceuticals, INC | $18.65 | 2020 | |
| Edwards Lifesciences Corporation | $17.36 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $17.07 | 2025 | Eliquis |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ekos Corporation | $16.38 | 2019 | |
| Lilly USA, LLC | $15.60 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Walters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.